Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (17)

2024

  1. Characterizing the “iceberg peak” in valvular heart disease: Outcomes and costs of in-hospital procedures in Spain

    REC: CardioClinics

2023

  1. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

2021

  1. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

2020

  1. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  2. Impact of antithrombotic treatment and geriatric syndromes in octogenarians with atrial fibrillation and ischaemic heart disease. Atrial Fibrillation and Ischemic Heart Disease in the Elderly

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 6, pp. 338-342

2019

  1. Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block Following TAVR

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 12, pp. 1175-1184

2018

  1. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

    JACC: Cardiovascular Interventions, Vol. 11, Núm. 3, pp. 301-310

2017

  1. Outcomes and predictors of success and complications for paravalvular leak closure: An analysis of the Spanish realwOrld paravalvular LEaks closure (HOLE) registry

    EuroIntervention, Vol. 12, Núm. 16, pp. 1962-1968

2013

  1. Effect of elevated pulmonary vascular resistance on outcomes after percutaneous mitral valvuloplasty

    American Journal of Cardiology, Vol. 112, Núm. 4, pp. 580-584

  2. The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results

    International Journal of Cardiology, Vol. 169, Núm. 5, pp. 359-365

2011

  1. Difference in outcome among women and men after percutaneous mitral valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 77, Núm. 1, pp. 115-120

2009

  1. Impact of Pre- and Postprocedural Mitral Regurgitation on Outcomes After Percutaneous Mitral Valvuloplasty for Mitral Stenosis

    American Journal of Cardiology, Vol. 104, Núm. 8, pp. 1122-1127

  2. Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score

    American Journal of Medicine, Vol. 122, Núm. 6

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  2. Impact of concomitant aortic regurgitation on percutaneous mitral valvuloplasty: Immediate results, short-term, and long-term outcome

    American Heart Journal, Vol. 156, Núm. 2, pp. 361-366

2007

  1. Heparin-induced thrombocytopenia

    Revista Espanola de Cardiologia, Vol. 60, Núm. 10, pp. 1071-1082